RxSight, Inc. to Present at the J.P. Morgan Healthcare Conference
RxSight (NASDAQ: RXST), an ophthalmic medical device company focused on providing customized vision solutions for post-cataract surgery patients, has announced its participation in the upcoming J.P. Morgan Healthcare Conference. The company's management team will deliver a presentation on Wednesday, January 15, 2025, at 9:45 a.m. Pacific Time / 12:45 p.m. Eastern Time. Investors and interested parties can access both the live presentation and archived webcast through the company's investor relations website at investors.rxsight.com.
RxSight (NASDAQ: RXST), un'azienda di dispositivi medici oftalmici focalizzata sulla fornitura di soluzioni visive personalizzate per i pazienti dopo interventi di cataratta, ha annunciato la sua partecipazione alla prossima J.P. Morgan Healthcare Conference. Il team di gestione dell'azienda terrà una presentazione mercoledì 15 gennaio 2025, alle 9:45 ora del Pacifico / 12:45 ora dell'Est. Gli investitori e le parti interessate possono accedere sia alla presentazione dal vivo che alla registrazione della webcast attraverso il sito web delle relazioni con gli investitori dell'azienda su investors.rxsight.com.
RxSight (NASDAQ: RXST), una empresa de dispositivos médicos oftálmicos centrada en proporcionar soluciones de visión personalizadas para pacientes después de la cirugía de cataratas, ha anunciado su participación en la próxima J.P. Morgan Healthcare Conference. El equipo directivo de la empresa presentará el miércoles 15 de enero de 2025, a las 9:45 a.m. hora del Pacífico / 12:45 p.m. hora del Este. Los inversores y partes interesadas pueden acceder tanto a la presentación en vivo como a la grabación web a través del sitio web de relaciones con inversores de la empresa en investors.rxsight.com.
RxSight (NASDAQ: RXST), 백내장 수술 후 환자를 위한 맞춤형 시력 솔루션 제공에 중점을 둔 안과 의료 기기 회사가 다가오는 J.P. Morgan Healthcare Conference에 참여한다고 발표했습니다. 회사의 경영팀은 2025년 1월 15일 수요일, 태평양 표준시 오전 9:45 / 동부 표준시 오후 12:45에 발표를 진행할 예정입니다. 투자자 및 관심 있는 당사자는 회사의 투자자 관계 웹사이트인 investors.rxsight.com을 통해 실시간 발표와 아카이브된 웹캐스트에 모두 액세스할 수 있습니다.
RxSight (NASDAQ: RXST), une entreprise de dispositifs médicaux ophtalmiques axée sur la fourniture de solutions visuelles personnalisées pour les patients après une chirurgie de la cataracte, a annoncé sa participation à la prochaine J.P. Morgan Healthcare Conference. L'équipe de direction de l'entreprise présentera le mercredi 15 janvier 2025, à 9h45, heure du Pacifique / 12h45, heure de l'Est. Les investisseurs et les parties intéressées peuvent accéder à la présentation en direct ainsi qu'à l'enregistrement de la diffusion sur le site Web des relations avec les investisseurs de l'entreprise à l'adresse investors.rxsight.com.
RxSight (NASDAQ: RXST), ein Unternehmen für ophthalmologische Medizintechnik, das sich auf die Bereitstellung maßgeschneiderter Sehlösungen für Patienten nach Kataraktoperationen spezialisiert hat, hat seine Teilnahme an der bevorstehenden J.P. Morgan Healthcare Conference bekannt gegeben. Das Management-Team des Unternehmens wird am Mittwoch, den 15. Januar 2025, um 9:45 Uhr Pazifischer Zeit / 12:45 Uhr Östlicher Zeit eine Präsentation halten. Investoren und interessierte Parteien können sowohl auf die Live-Präsentation als auch auf die archivierte Übertragung über die Investoren-Website des Unternehmens unter investors.rxsight.com zugreifen.
- None.
- None.
ALISO VIEJO, Calif., Jan. 02, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced plans to participate in the upcoming J.P. Morgan Healthcare Conference.
RxSight’s management is scheduled to present on Wednesday, January 15, 2025, at 9:45 a.m. Pacific Time / 12:45 p.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation at: https://investors.rxsight.com/.
About RxSight, Inc.
RxSight, Inc. is an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery. The RxSight® Light Adjustable Lens system, comprised of the RxSight Light Adjustable Lens® (LAL™/LAL+®, collectively the “LAL”), RxSight Light Delivery Device (LDD™) and accessories, is the first and only commercially available intraocular lens (IOL) technology that can be adjusted after surgery, enabling doctors to customize and deliver high-quality vision to patients after cataract surgery. Additional information about RxSight can be found at www.rxsight.com.
Company Contact:
Shelley B. Thunen
Chief Financial Officer
sthunen@rxsight.com
Investor Relations Contact:
Oliver Moravcevic
VP, Investor Relations
omoravcevic@rxsight.com
FAQ
When is RxSight (RXST) presenting at the J.P. Morgan Healthcare Conference 2025?
How can investors watch RxSight's (RXST) J.P. Morgan Healthcare Conference presentation?
What is RxSight's (RXST) main business focus?
Will RxSight's (RXST) J.P. Morgan Healthcare Conference presentation be available after the event?
